Futura Medical Share Discussion Threads

[lbo] 01/12/2022 16:36

Its all a ramper swindle to try dupe the naive into buying shares in a placebo gel.

[petroc] 01/12/2022 16:30

Stock bashing has become very common in the digital world and often occurs on online trading platforms. Sophisticated technology makes it easy for bashers to remain anonymous. As such, it can be difficult to track, identify, and stop bashers in their tracks.

As the internet makes participation in the stock market more accessible to more people, new investors emerging in the market are especially vulnerable to the tactics of stock bashers, and many investor boards exist to attempt to track perpetrators.

Though notoriously difficult to track, some bashers have been identified and prosecuted. From time to time, confessional essays about the tactics of bashers emerge online, although these essays are typically also either anonymous or pseudonymous. Many investors speculate this type of behavior tends to follow certain patterns, including a tendency for bashers to only bash stocks which are generally trending upwards and showing potential.

Having said that, financial regulators constantly monitor the markets for what they call bad actors or stock bashers. According to the Financial Industry Regulatory Authority (FINRA), investors may find it difficult to get information about these securities and any tidbits they may find can lead them to act—even if it's misinformation. That's why FINRA warned investment firms and broker-dealers to put controls in place that would raise red flags on any suspicious activity.

[petroc] 01/12/2022 16:29

Interestingly, as part of its due diligence, Cooper undertook a consumer
marketing home use test (HUT) in the UK, France, and the Netherlands. The
size of the HUT is not disclosed but would typically involve c 200 consumers.
In this case men with self-diagnosed ED were supplied a four-pack sample of
MED3000 with the appropriate packaging leaflet. The results were in line
with those seen in the FM57 1,000 patient clinical trial, where over two thirds of patients saw a clinically meaningful benefit. The importance of the
HUT lies in the confirmation that MED3000 works as expected in a realworld setting. Longer-term use is being explored in the c 100 patient FM71
clinical trial, conducted over 24 weeks, to support the FDA application.

[petroc] 01/12/2022 16:28

How to spot a discussion board stock basher.

They post their lies and manipulations over and over and over desperately hoping to move the market. They never do.

[lbo] 01/12/2022 16:23

5. They post their predictions over and over and over desperately hoping to move the market. They never do

[broomrigg] 01/12/2022 16:05

Product launch getting close, re-rating on its way....that's why the shares have good support.94p will look cheap.

[lbo] 01/12/2022 15:20

Manufactured PET500 was also ready to be sold yet it failed to sell on the market even with a partner like Ansell selling it in Walmart. Same with CSD500 and all their partners and it too also failed to meet expectations. While TPR1000 has been limbo since 2017 when it’s ‘manufacturing scale up’ was announced!




mikethebike4 - 24 Feb 2020 - 09:11:58 - 7290 of 9713

why should it be any different this time when you've still got the same useless lot running the show


And here are Futura over 20 years later back selling the same story with yet another medical device. But this time with even more questionable efficacy claims and patentability. Do you remember the last thing Futura said about its last medical device CSD500 in 2018? Before Med2002 failed its phase 3 which low and behold also left it having to become yet another medical device.



˜Futura does not have the marketing or regulatory resources to support the day-to-day requirements in a growing compliance-driven medical device market’

˜the immediate potential for substantial royalties is low in the absence of a large global brand 'carrier' to take the product forward’

[lbo] 01/12/2022 15:06

There was only 96 men in FM71 so less then 50 men actually used MED3000. There was also burning reported by some of the men and women in FM57 and there was also adverse events reported in 18.5% of the placebo gel users in FM53.

Yet millions and millions of men have used Viagra safely over many many years. So thats billions of doses taken yet its only linked to a few deaths. More men die from deaths associated with alcohol ingestion per year.And even placebo gels like MED3000 will be associated with deaths if taken by enough men over time.

The objective data over many years of use. After appropriate assessment and correct use has proven Viagra to be effective and safe. Viagra has a well-established efficacy and tolerability profile. From its introduction in 1998 to 2016, over 64m men worldwide were treated with sildenafil citrate. 'The safety profile of sildenafil citrate is based on over 9,570 patients in 74 double blind placebo-controlled clinical studies as well as postmarketing surveillance that has been gathered over 10 years.' And correlation is not causation.

Viagra studies have even showed men taking it live longer.



With many millions of men taking erection erection drugs. Lots of men with heart disease will die from that heart disease whether or not they take erection medication. That is all it is, an association. There’s s no proof of cause and effect. And the data actually shows men with CVS disease who take viagra live longer.





New research has found that half of participants who took a placebo in a clinical trial reported suffering from an adverse event (a side effect of the trial intervention). More surprisingly, 1 in 20 people who were taking placebos dropped out of their trials because of more serious adverse events. The study included data from 1,271 randomized trials and 250,726 trial participants. The adverse events ranged from abdominal pain and anorexia to burning, chest pain, fatigue, and even death

[j777j] 01/12/2022 15:04

Manufactured products ready for sale

Just a matter of time now before EU and Uk launch announcements

Trinity delta last price target 94p with upgrades to follow

[lbo] 01/12/2022 14:59

Dr. Burnett on Viagra: “This transformed the field in a significant way”

What do you foresee as innovations on the horizon for ED treatment in the near future?
In the next year, we don't have a whole lot more than what I just mentioned




Its all in the American Urological Association [AUA] guidelines

The therapies have not been validated

I recommend what we have as standard of care, which includes pills, injections, penile prosthesis, and vacuum devices that we know work. Other therapies have not been included in the standard of care yet’

The first line therapy recommended in the General practice guidelines on ED is oral PDE5I drugs. Which would be based on all the available objective evidence. It would not be based solely on a rampers subjective and unqualified personal view. Or if a person just own shares in a company with a placebo gel alternative and who may have a vested interest and biased opinion.



First-line therapy

For most men with ongoing confirmed ED, first-line treatment will be a phosphodiesterase-5 inhibitor (PDE5I).



Phosphodiesterase 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil) are recommended as first-line therapy. With established safety profiles, these drugs are well tolerated and effective

GPC prescribing lead Dr Andrew Green:

'There is no doubt that sildenafil is a safe and effective drugâ€â„

[lbo] 01/12/2022 14:54

A Viagra study also showed using a placebo was also just as likely to harm you. It compared some 4,500 patients taking the drug to about 3,100 on placebo. So based on that study Med3000 even as a placebo is just as likely to harm you as viagra.



The principle of informed consent obligates physicians to explain possible side effects when prescribing medications. This disclosure may itself induce adverse effects through expectancy mechanisms known as nocebo effects, contradicting the principle of nonmaleficence. Rigorous research suggests that providing patients with a detailed enumeration of every possible adverse event-especially subjective self-appraised symptoms-can actually increase side effects. Describing one version of what might happen (clinical "facts") may actually create outcomes that are different from what would have happened without this information (another version of "facts"). This essay argues that the perceived tension between balancing informed consent with nonmaleficence might be resolved by recognizing that adverse effects have no clear black or white "truth." This essay suggests a pragmatic approach for providers to minimize nocebo responses while still maintaining patient autonomy through "contextualized informed consent," which takes into account possible side effects, the patient being treated, and the particular diagnosis involved.

[lbo] 01/12/2022 14:44

It is known that uncontrolled trials produce higher estimates of the mean effect than those obtained in a controlled trial, since by not having a control group acting as a reference, they can induce erroneous impressions about the results of the investigated drug. As they can generate a certain bias, the results of uncontrolled trials are considered less valid than those of controlled trials.

[lbo] 01/12/2022 14:08

Deja Vu! 3 years later! LOLJ777J 28 Nov '19 - 07:35 - 6443 of 14369 New 15 page buy note out today from Liberum.A strong positive outcome would imply 149p share price.

[j777j] 01/12/2022 13:14

About to hit the most exciting time in the company's history

Multibagger right here

[lbo] 01/12/2022 12:28

How many times have you repeatedly posted the same misleading post now? Oral PDE5i drugs are the proven safe, effective and recent first line therapy for ED according to people and organisations who are qualified to make those recommendations.You have also deliberately and repeatedly misrepresented the side effects and risks of the recommended first line therapy. It has many years of objective data in millions of users supporting why it is still the recommended first line therapy. Unlike Med3000 which has no non deficient data supporting its efficacy and very little and very short term safety data only in a very few number of users.



A Viagra study also showed using a placebo was also just as likely to harm you. It compared some 4,500 patients taking the drug to about 3,100 on placebo. So based on that study Med3000 even as a placebo is just as likely to harm you as viagra.



Its all in the American Urological Association [AUA] guidelinesâ’

The therapies have not been validated’

˜I recommend what we have as standard of care, which includes pills, injections, penile prosthesis, and vacuum devices that we know work. Other therapies have not been included in the standard of care yet’

The first line therapy recommended in the General practice guidelines on ED is oral PDE5I drugs. Which would be based on all the available objective evidence. It would not be based solely on a rampers subjective and unqualified personal view. Or if a person just own shares in a company with a placebo gel alternative and who may have a vested interest and biased opinion.



First-line therapy

For most men with ongoing confirmed ED, first-line treatment will be a phosphodiesterase-5 inhibitor (PDE5I).



Phosphodiesterase 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil) are recommended as first-line therapy. With established safety profiles, these drugs are well tolerated and effective

GPC prescribing lead Dr Andrew Green:

'There is no doubt that sildenafil is a safe and effective drug’